ERBB2 and breast cancer: Through cell total number assay, MTT assay, cell colony formation assay and flow cytometry, the HER2-nanobody constructed was examined to suppress cell proliferation, mitosis and stimulate apoptosis in HER2-positive breast cancer cells.